
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of SUSTOL, ZYNRELEF, and CINVANTI. Its pipeline product is HTX-011. Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of SUSTOL, ZYNRELEF, and CINVANTI. Its pipeline product is HTX-011.
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.05 | 2.29357798165 | 2.18 | 2.3 | 2.11 | 1448139 | 2.16620751 | CS |
4 | 0.11 | 5.18867924528 | 2.12 | 2.3 | 1.9029 | 1629840 | 2.09828396 | CS |
12 | 0.34 | 17.9894179894 | 1.89 | 2.61 | 1.7 | 1622117 | 2.09787487 | CS |
26 | 0.63 | 39.375 | 1.6 | 2.68 | 1.46 | 1652082 | 2.066151 | CS |
52 | -0.74 | -24.9158249158 | 2.97 | 3.73 | 1.04 | 2167755 | 1.94655103 | CS |
156 | -1.07 | -32.4242424242 | 3.3 | 5.62 | 0.5 | 2435755 | 2.33111148 | CS |
260 | -13.25 | -85.5943152455 | 15.48 | 22.4 | 0.5 | 2095106 | 4.83783634 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.